In a report released yesterday, Ben Hendrix from RBC Capital reiterated a Buy rating on UnitedHealth (UNH – Research Report), with a price target of $555.00. The company’s shares closed yesterday at $468.89.
According to TipRanks, Hendrix is a 3-star analyst with an average return of 1.9% and a 50.52% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Cigna, Brookdale Senior Living, and HCA Healthcare.
In addition to RBC Capital, UnitedHealth also received a Buy from Barclays’s Andrew Mok CFA in a report issued today. However, on April 12, Jefferies maintained a Hold rating on UnitedHealth (NYSE: UNH).
UNH market cap is currently $410.8B and has a P/E ratio of 18.68.
Based on the recent corporate insider activity of 146 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of UNH in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
UnitedHealth (UNH) Company Description:
UnitedHealth Group, Inc. is a diversified healthcare company, offering healthcare coverage and benefits services through UnitedHealthcare, and information and technology-enabled health services through Optum. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN.
Read More on UNH:
- UNH Earnings: UnitedHealth Jumps on Resilient Q1 Performance
- Options Volatility and Implied Earnings Moves Today, April 16, 2024
- UnitedHealth backs FY24 adjusted EPS view $27.50-$28.00, consensus $27.52
- UnitedHealth reports Q1 adjusted EPS $6.91, consensus $6.62
- Notable companies reporting before tomorrow’s open
